FDA Approves First Generic of Symbicort to Treat Asthma and COPD
For Immediate Release: March 15, 2022 Today, the U.S. Food and Drug Administration approved the first generic of Symbicort (budesonide and formoterol fumarate dihydrate) Inhalation Aerosol for the treatment of two common pulmonary health conditions: asthma …